Skip to main content

Table 1 The expressional alterations of mutated genes

From: Systematical identifications of prognostic meaningful lung adenocarcinoma subtypes and the underlying mutational and expressional characters

Gene

Fold Change

P-value

KRAS

1.09

1.5E-16

SMAD4

0.92

8.4E-4

SMARCA4

0.86

1.2E-4

STK11

0.92

3.1E-7

EGFR

1.24

3.0E-13

KEAP1

1.04

4.2E-7

TP53

0.96

2.1E-3

RB1

0.93

2.9E-4

RBM10

0.79

5.5E-12

COL11A1

1.26

1.4E-2

NF1

0.94

3.4E-3

SETD2

0.97

1.2E-2

CDKN2A

1.93

9.8E-7

ARID1A

1.00

0.85

B2M

0.96

0.26

BRAF

1.02

0.32

TCEAL5

1.06

0.97

ZFP36L1

1.04

0.15

MGA

0.95

0.097

ZNF679

0.93

0.16

  1. Note: Fold change: examine the fold change in mRNA expression level of one gene between samples with mutated and wild type gene status; P-value: Wilcox-test, unpaired, two sided
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us